Interleukin 2 News and Research

RSS

Machine learning model for prediction of COVID-19 patient mortality risk

A new preprint reports a novel machine learning model that purportedly predicts the mortality risk of COVID-19 in patients accurately and at an early stage of infection.

18 Jan 2022

WHO's recommendation provides two new options for treating COVID-19

WHO has recommended two new drugs for COVID-19, providing yet more options for treating the disease. The extent to which these medicines will save lives depends on how widely available and affordable they will be.

16 Jan 2022

Role of leptin in immune modulation and pathophysiology of COVID-19

A recent review paper in the journal Frontiers in Physiology discusses the role of leptins in infection with SARS-CoV-2 that triggered the ongoing COVID-19 pandemic.

13 Jan 2022

Living alone, serial break-ups may raise the levels of inflammatory markers in men

Living alone for several years and/or experiencing serial relationship break-ups are strongly linked to raised levels of inflammatory markers in the blood-but only in men-finds a large population study published online in the Journal of Epidemiology & Community Health.

12 Jan 2022

Cellular and humoral response to SARS-CoV-2 in multiple sclerosis patients using disease-modifying therapies

Researchers examine the effects of disease-modifying therapies implemented for treating multiple sclerosis on the immune response to SARS-CoV-2 infection.

12 Jan 2022

A common cold may boost the immune system against COVID-19

A recent groundbreaking research paper published in the journal Nature Communications reveals the association of circulating SARS-CoV-2-specific T cells at exposure with lack of infection – implying the protective role for cross-reactive immune T cells in coronavirus disease 2019 (COVID-19) and opening the door for second-generation vaccines that could circumvent spike-antibody immune escape variants.

11 Jan 2022

Impact of post-exposure BNT162b2 prophylaxis against SARS-CoV-2 infections

In a new study, researchers determined evidence for post-exposure vaccination in reducing the mortality rate of COVID-19 and concluded that post-exposure prophylaxis successfully decreased SARS-CoV-2-associated death rates.

11 Jan 2022

Study finds heterologous vaccine booster evokes robust immunity to SARS-CoV-2 Omicron variant

The current study examines the role of heterologous vaccination, an area that lacks much clarity.

11 Jan 2022

Mapping peripheral blood glycoprotein profiles of COVID-19 patients

A team of researchers recently analyzed differential protein glyco-isoform distributions of symptomatic and asymptomatic coronavirus disease 2019 patients.

11 Jan 2022

Immunological factors associated with impaired BNT162b2 mRNA vaccine response in older adults

A new study posted to the pre-print server medRxiv* investigated the significant immune alterations concerning SARS-CoV-2 specific innate and adaptive immunity associated with a lower BNT162b2 mRNA vaccine response in older individuals.

10 Jan 2022

Exploring neurodevelopmental effects on infants from in-utero exposure to COVID-19

A new study aimed to determine the associations between fetal exposure to maternal SARS-CoV-2 infection, in-utero, and child neurodevelopmental status.

7 Jan 2022

Scientists unravel how LPS prevents or promotes development of allergic disease

Immunologists have long been baffled by LPS, the bacterial lipopolysaccharide that helps form the cell walls of Gram-negative bacteria.

5 Jan 2022

New approach could offer a more accurate way to evaluate donor kidney quality

A new way to evaluate the quality of kidneys before transplantation could one day help increase the number of usable donor kidneys.

5 Jan 2022

Exploring vaccine-induced cellular immunity against SARS-CoV-2 Omicron variant

In a new study, researchers determined CD8+ and CD4+ T cell responses against the SARS-CoV-2 Omicron variant in 51 individuals vaccinated with the messenger ribonucleic acid (mRNA)-based Pfizer and adenovirus vector-based Johnson & Johnson vaccines.

5 Jan 2022

Children with pre-existing immunity to common cold demonstrate better protection against COVID-19

New data shows that, compared to adults, children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) preferentially activate pre-existing acquired immunity to prevalent common cold coronaviruses that cross-react with SARS-CoV-2 and protect them from severe disease.

24 Dec 2021

Exploring why children have milder COVID-19 infections compared to adults

A new study has revealed that an activated pre-exposure innate interferon response in airways together with significantly reduced systemic interferon-stimulated populations are associated with relatively milder severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children.

23 Dec 2021

Interleukin 2 News and Research

Machine learning model for prediction of COVID-19 patient mortality risk

WHO's recommendation provides two new options for treating COVID-19

Role of leptin in immune modulation and pathophysiology of COVID-19

Living alone, serial break-ups may raise the levels of inflammatory markers in men

Cellular and humoral response to SARS-CoV-2 in multiple sclerosis patients using disease-modifying therapies

A common cold may boost the immune system against COVID-19

Impact of post-exposure BNT162b2 prophylaxis against SARS-CoV-2 infections

Study finds heterologous vaccine booster evokes robust immunity to SARS-CoV-2 Omicron variant

Mapping peripheral blood glycoprotein profiles of COVID-19 patients

Immunological factors associated with impaired BNT162b2 mRNA vaccine response in older adults

Exploring neurodevelopmental effects on infants from in-utero exposure to COVID-19

Scientists unravel how LPS prevents or promotes development of allergic disease

New approach could offer a more accurate way to evaluate donor kidney quality

Exploring vaccine-induced cellular immunity against SARS-CoV-2 Omicron variant

Children with pre-existing immunity to common cold demonstrate better protection against COVID-19

Exploring why children have milder COVID-19 infections compared to adults

rVSV-based bivalent vaccine against SARS-CoV-2 delta variant and influenza

Exploring the Mediterranean diet as a potential strategy against SARS-CoV-2

Impact of acute kidney injury associated gene expression in human kidney cells

Echinacea purpurea may help prevent respiratory tract infections during COVID-19 pandemic

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News